dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
diclofenacnatrium "europharma" 100 mg suppositorier
europharma.dk aps - diclofenacnatrium - suppositorier - 100 mg
spironolactone ceva
ceva santé animale - spironolacton - diuretika - hunde - til anvendelse i kombination med standardterapi (herunder diuretisk støtte, hvor det er nødvendigt) til behandling af kongestivt hjertesvigt forårsaget af valvular regurgitation hos hunde.
lamivudine teva pharma b.v.
teva b.v. - lamivudin - hiv infektioner - antivirale midler til systemisk anvendelse - lamivudin teva pharma b. indikeres som en del af antiretroviral kombinationsbehandling til behandling af humane immunsvigt-virus (hiv) -inficerede voksne og børn.
ledaga
helsinn birex pharmaceuticals ltd. - chlormethine - mycosis fungoides - antineoplastiske midler - ledaga er indiceret til topisk behandling af mycosis fungoides-type kutant t-celle lymfom (mf-type ctcl) hos voksne patienter.
cetraxal 2 mg/ml øredråber, opløsning i enkeltdosisbeholder
poa pharma scandinavia ab - ciprofloxacin - øredråber, opløsning i enkeltdosisbeholder - 2 mg/ml
diclofenacnatrium "stulln" 1 mg/ml øjendråber, opløsning, enkeltdosisbeholder
pharma stulln gmbh - diclofenacnatrium - øjendråber, opløsning, enkeltdosisbeholder - 1 mg/ml
hydroxyzinhydrochlorid "eql pharma" 25 mg filmovertrukne tabletter
eql pharma ab - hydroxyzinhydrochlorid - filmovertrukne tabletter - 25 mg
lacidipin "double-e pharma" 2 mg filmovertrukne tabletter
double-e-pharma ltd. - lacidipin - filmovertrukne tabletter - 2 mg
lacidipin "double-e pharma" 6 mg filmovertrukne tabletter
double-e-pharma ltd. - lacidipin - filmovertrukne tabletter - 6 mg